Literature DB >> 32616581

Focal Leptomeningeal Disease with Perivascular Invasion in EGFR-Mutant Non-Small-Cell Lung Cancer.

A Dasgupta1, F Y Moraes1, S Rawal1, P Diamandis1, D B Shultz2.   

Abstract

We report a previously undescribed pattern of brain metastases in patients with epidermal growth factor receptor-mutated non-small-cell lung cancer treated with tyrosine kinase inhibitors and radiation therapy. These highly distinct lesions appear to spread focally within the leptomeninges, with invasion along the perivascular spaces (FLIP). The survival of patients with FLIP was significantly better compared with patients with classic leptomeningeal disease (median survival, 21 versus 3 months; P = .003). It is unclear whether this pattern of growth is unique to epidermal growth factor receptor-mutated non-small-cell lung cancer.
© 2020 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32616581      PMCID: PMC7658871          DOI: 10.3174/ajnr.A6640

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  12 in total

Review 1.  Virchow-Robin spaces on magnetic resonance images: normative data, their dilatation, and a review of the literature.

Authors:  Samuel Groeschel; Wui Khean Chong; Robert Surtees; Folker Hanefeld
Journal:  Neuroradiology       Date:  2006-08-05       Impact factor: 2.804

2.  Stereotactic radiosurgery for focal leptomeningeal disease in patients with brain metastases.

Authors:  Amparo Wolf; Bernadine Donahue; Joshua S Silverman; Abraham Chachoua; Jean K Lee; Douglas Kondziolka
Journal:  J Neurooncol       Date:  2017-05-23       Impact factor: 4.130

3.  Serpins promote cancer cell survival and vascular co-option in brain metastasis.

Authors:  Manuel Valiente; Anna C Obenauf; Xin Jin; Qing Chen; Xiang H-F Zhang; Derek J Lee; Jamie E Chaft; Mark G Kris; Jason T Huse; Edi Brogi; Joan Massagué
Journal:  Cell       Date:  2014-02-27       Impact factor: 41.582

4.  Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis.

Authors:  Bin-Chi Liao; Jih-Hsiang Lee; Chia-Chi Lin; Ya-Fang Chen; Chin-Hao Chang; Chao-Chi Ho; Jin-Yuan Shih; Chong-Jen Yu; James Chih-Hsin Yang
Journal:  J Thorac Oncol       Date:  2015-12       Impact factor: 15.609

5.  Association of Neurosurgical Resection With Development of Pachymeningeal Seeding in Patients With Brain Metastases.

Authors:  Daniel N Cagney; Nayan Lamba; Sumi Sinha; Paul J Catalano; Wenya Linda Bi; Brian M Alexander; Ayal A Aizer
Journal:  JAMA Oncol       Date:  2019-05-01       Impact factor: 31.777

6.  Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain Metastases.

Authors:  Matthew Ramotar; Sierra Barnes; Fabio Moraes; Archya Dasgupta; Normand Laperriere; Barbara-Ann Millar; Alejandro Berlin; Tatiana Conrad; Monique van Prooijen; Andrei Damyanovich; Robert Heaton; Young-Bin Cho; Catherine Coolens; Geoffrey Liu; Frances A Shepherd; Penelope Bradbury; Natasha Leighl; Mark Bernstein; Gelareh Zadeh; Paul Kongkham; Mark Doherty; David B Shultz
Journal:  Adv Radiat Oncol       Date:  2019-11-26

7.  Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study.

Authors:  James C H Yang; Sang-We Kim; Dong-Wan Kim; Jong-Seok Lee; Byoung Chul Cho; Jin-Seok Ahn; Dae H Lee; Tae Min Kim; Jonathan W Goldman; Ronald B Natale; Andrew P Brown; Barbara Collins; Juliann Chmielecki; Karthick Vishwanathan; Ariadna Mendoza-Naranjo; Myung-Ju Ahn
Journal:  J Clin Oncol       Date:  2019-12-06       Impact factor: 44.544

8.  Brain MRI imaging characteristics predict treatment response and outcome in patients with de novo brain metastasis of EGFR-mutated NSCLC.

Authors:  Chia-Ying Lin; Chao-Chun Chang; Po-Lan Su; Chien-Chung Lin; Yau-Lin Tseng; Wu-Chou Su; Yi-Ting Yen
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

9.  Radiographic appearance of leptomeningeal disease in patients with EGFR-mutated non-small-cell lung carcinoma treated with tyrosine kinase inhibitors: a case series.

Authors:  Ugur Sener; Nassim Matin; Helena Yu; Andrew Lin; T Jonathan Yang; Rachna Malani
Journal:  CNS Oncol       Date:  2019-11-28

10.  Imaging of Angiotropism/Vascular Co-Option in a Murine Model of Brain Melanoma: Implications for Melanoma Progression along Extravascular Pathways.

Authors:  Laurent A Bentolila; Roshini Prakash; Daniela Mihic-Probst; Madhuri Wadehra; Hynda K Kleinman; Thomas S Carmichael; Bruno Péault; Raymond L Barnhill; Claire Lugassy
Journal:  Sci Rep       Date:  2016-04-06       Impact factor: 4.379

View more
  1 in total

1.  Case Report: Focal leptomeningeal disease, atypical cancer of unknown primary site.

Authors:  Miguel A Vences; Mary M Araujo-Chumacero; Diego Urrunaga-Pastor; Leila Barreto; Liliana Rodríguez-Kadota; Elliot Barreto-Acevedo; César Saavedra-Rocha; Elder V Quispe-Huamaní
Journal:  F1000Res       Date:  2022-08-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.